Additionally, both forward and reverse IP experiments revealed no detectable interactions between EphA2 and EFNA2 or EFNA5 (Supplemental Figure 14), suggesting that other receptors and downstream pathways may mediate the tumor-suppressive roles of EFNA2 and EFNA5 (Supplemental Figure 10). Here, EFNA5 is linked to neoplasm.